The central cardiovascular effects of neuropeptide Y (NPY) have been investigated by
microinjection of the peptide into the hypothalamic paraventricular nucleus (PVN) of …

The haemodynamic effects of intracerebroventricular (icv) administration of neuropeptide Y
(NPY) in urethane-anaesthetized rats were studied. In Sprague-Dawley rats, NPY increased …

The cardiovascular actions of intracerebroventricular (icv) administration of neuropeptide Y
(NPY) were examined in conscious, unrestrained rats. A prolonged decrease in heart rate …

The central haemodynamic effects of neuropeptide Y (NPY), both alone and together with
either noradrenaline (NA) or vasopressin (AVP), have been investigated by microinjecting …

The cardiovascular effects of intracisternal and intraparenchymal injection of neuropeptide Y
(NPY) into the caudal ventrolateral medulla (CVLM) were investigated in anaesthetized …

Central catecholaminergic neurons are involved in cardiovascular regulation. Neuropeptide
Y (NPY) coexists with adrenaline and noradrenaline in the rat brain, and interactions among …

Unilateral microinjection of neuropeptide Y (NPY) into the posterior hypothalamic nucleus
was previously found to evoke a sympathoexcitatory-mediated increase in mean arterial …

The effect of the intrathecal administration of neuropeptide Y (NPY) on blood pressure and
heart rate of anesthetized normotensive and hypertensive rats was studied. Neuropeptide Y …

We evaluated the potential participation of endogenous brain neuropeptide Y (NPY) in
central cardiovascular regulation, using adult male Sprague-Dawley rats anesthetized with …

NPY (lng-10/ug) had no effect on mean arterial pressure (MAP) or heart rate (HR) when
administered into the lateral brain ventricle or cisterna magna of conscious, chronically …